درباره این اپیزود
One of the most active areas in HIV research is ART switch strategies in virologically suppressed patients with HIV (PWH). Recent switch studies highlight the use of INSTI-, non-INSTI, and long-acting ART regimens as well as a shifting in strategies–from one of only achieving viral suppression towards also addressing simplification, minimizing long-term toxicities, managing comorbidities, and improving quality of life. This activity is designed to update healthcare professionals with the latest cutting-edge evidence on ART switch strategies in virologically suppressed PWH that were reported in 2025 as well as discuss their implications on patient management trends for 2026.
Launch/Release Date: November 24, 2025
Activity Expiration Date: October 31, 2026
FACULTY
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
